Repurposing mirabegron, a drug used to treat overactive bladder disease, did not significantly change left ventricular mass index or diastolic function in pre–heart failure structural heart disease.
Source: https://www.medscape.com/viewarticle/996645?src=mbl_msp_android&ref=share